VYNE
VYNE Therapeutics is a New Jersey-based biotechnology company that researches, develops and commercializes medicines for the treatment of pruritus.
Business Model:
Revenue: $14.6M
Employees: 11-50
Industries / Tags:
Detailed VYNE Information
Geographic Data
Address: 520 U.S. Highway 22
City: Bridgewater
State: NJ
Zip: 07920
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$50M
Raised Total:$160M
Social
Metrics
9,500,285Website Global Rank
147Website Monthly Traffic
Twitter Followers
Description
VYNE Therapeutics is a New Jersey-based biotechnology company that researches, develops and commercializes medicines for the treatment of pruritus.
Contact Phone:
+18007757936
Contact Email:
VYNE went public on 1/24/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/24/2018
IPO Valuation:
$372M
Ticker Symbol:
VYNE
IPO Price:
$17/share
Amount Raised:
$137M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2015 | Series A | 2 | $14.3M |
CMEA Capital Remeditex Ventures CMEA Capital Remeditex Ventures |
1/2021 | Post-IPO Equity | $50M | 1/2018 | IPO | $127.1M | 12/2012 | Equity | $500k | 1/2021 | Post-IPO Equity | $46.7M | 7/2017 | Series C | 9 | $50.5M |
Remeditex Ventures Presidio Partners Rock Springs Capital F-Prime Capital venBio Partners Aisling Capital Novo Holdings Vivo Capital Bay City Capital venBio Partners Remeditex Ventures Presidio Partners Rock Springs Capital F-Prime Capital venBio Partners Aisling Capital Novo Holdings Vivo Capital Bay City Capital venBio Partners |
7/2017 | Series C | $50.5M |
venBio Novo Holdings A/S Rock Springs Capital Aisling Capital Bay City Capital Vivo Capital Presidio Partners Remeditex F-Prime Capital |
11/2015 | Series B | 4 | $45M |
Presidio Partners Vivo Capital F-Prime Capital Remeditex Ventures Presidio Partners Vivo Capital |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2020 | Foamix |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
